Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-012344

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Patrick B Verguet
Officer — CVP, Europe
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 14, 2015A1,925$0.00A53,861D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F3$130.56May 14, 2015A20,800AJun 14, 2015May 13, 2022Common Stock20,80020,800D
Performance RightsF4,F2—May 14, 2015A2,400A—May 31, 2018Common Stock2,4002,400D

Explanation of responses